arrow
返回
D

Dean Ellison

merck & company

17H指数
54论文数
1.2K被引数
收录论文 10
发表时间
Use of a Quality-by-Design approach to justify removal of the HPLC weight % assay from routine API stability testing protocols
err2009-12-01
err20
PREAI
errSkrdla, Peter J.; Wang, Tao; Antonucci, Vincent; Dowling, Thomas; Ge, Zhihong; Ellison, Dean; Curran, John; Mohan, Ganapathy; Wyvratt, Jean
err分享
err收藏
A rationale for determining, testing, and controlling specific impurities in pharmaceuticals that possess potential for genotoxicity
err2006-04-01
err397
PREAI
errMüller, L; Mauthe, RJ; Riley, CM; Andino, MM; De Antonis, D; Beels, C; DeGeorge, J; De Knaep, AGM; Ellison, D; Fagerland, JA; Frank, R; Fritschel, B; Galloway, S; Harpur, E; Humfrey, CDN; Jacks, AS; Jagota, N; Mackinnon, J; Mohan, G; Ness, DK; O'Donovan, MR; Smith, MD; Vudathala, G; Yotti, L
err分享
err收藏
Practical aspects of fast HPLC separations for pharmaceutical process development using monolithic columns
err2004-10-01
err60
PREAI
errWu, NJ; Dempsey, J; Yehl, PM; Dovletoglou, A; Ellison, D; Wyvratt, J
err分享
err收藏
err分享
err收藏